Therapy-Related Myeloid Neoplasm Has a Higher Subclonal Mutation Burden Than De Novo AML

被引：0
|
作者：
Zheng, Gang [1 ]
Pallavajjalla, Aparna [1 ]
Haley, Lisa [1 ]
Lin, Ming-Tseh [1 ]
Eshleman, James R. [1 ]
Gondek, Lukasz [1 ]
Borowitz, Michael [1 ]
Duffield, Amy [1 ]
Burns, Kathleen H. [1 ]
Gocke, Christopher D. [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1555
引用
收藏
页码：388A / 388A
页数：1
相关论文
共 50 条
  • [31] Bone Marrow Cellularity during Induction Is Highly Predictive of Complete Remission in De Novo AML but Not in Secondary/Therapy-Related AML
    Zheng, G.
    DeZern, A. E.
    Pratz, K. W.
    Karp, J. E.
    Gocke, C. D.
    LABORATORY INVESTIGATION, 2012, 92 : 384A - 385A
  • [32] Molecular characterization of therapy-related MDS after curative intensive therapy for de novo acute myeloid leukemia
    Boettner, A.
    Herold, S.
    Helas, S.
    Sayehli, C.
    Duehrsen, U.
    Hindahl, H.
    Kullmer, J.
    Sauer, M.
    Mohr, B.
    Bornhaeuser, M.
    Ehninger, G.
    Roellig, C.
    Thiede, C.
    Platzbecker, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 235 - 236
  • [33] The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
    Deepak Singhal
    Li Yan A. Wee
    Monika M. Kutyna
    Rakchha Chhetri
    Joel Geoghegan
    Andreas W. Schreiber
    Jinghua Feng
    Paul P.-S. Wang
    Milena Babic
    Wendy T. Parker
    Smita Hiwase
    Suzanne Edwards
    Sarah Moore
    Susan Branford
    Teodora Kuzmanovic
    Nimit Singhal
    Raghu Gowda
    Anna L. Brown
    Peer Arts
    Luen B. To
    Peter G. Bardy
    Ian D. Lewis
    Richard J. D’Andrea
    Jaroslaw P. Maciejewski
    Hamish S. Scott
    Christopher N. Hahn
    Devendra K. Hiwase
    Leukemia, 2019, 33 : 2842 - 2853
  • [34] The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
    Singhal, Deepak
    Wee, Li Yan A.
    Kutyna, Monika M.
    Chhetri, Rakchha
    Geoghegan, Joel
    Schreiber, Andreas W.
    Feng, Jinghua
    Wang, Paul P. -S.
    Babic, Milena
    Parker, Wendy T.
    Hiwase, Smita
    Edwards, Suzanne
    Moore, Sarah
    Branford, Susan
    Kuzmanovic, Teodora
    Singhal, Nimit
    Gowda, Raghu
    Brown, Anna L.
    Arts, Peer
    To, Luen B.
    Bardy, Peter G.
    Lewis, Ian D.
    D'Andrea, Richard J.
    Maciejewski, Jaroslaw P.
    Scott, Hamish S.
    Hahn, Christopher N.
    Hiwase, Devendra K.
    LEUKEMIA, 2019, 33 (12) : 2842 - 2853
  • [35] Prognostic Implication of Therapy-Related Acute Myeloid Leukemia after Comparative Analysis with De Novo acute Myeloid Leukemia
    Yoon, Jae-Ho
    Cho, Byung-Sik
    Kim, Hee-Je
    Yahng, Seung-Ah
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    BLOOD, 2015, 126 (23)
  • [36] Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant
    Kim, Min Kyoung
    Cho, Hee Soon
    Bae, Young Kyung
    Lee, Kyung Hee
    Ki, Chang-Seok
    Lee, Seung-Tae
    Hyun, Myung Soo
    LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1144 - 1147
  • [37] Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML):: an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
    Schoch, C
    Kern, W
    Schnittger, S
    Hiddemann, W
    Haferlach, T
    LEUKEMIA, 2004, 18 (01) : 120 - 125
  • [38] Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
    C Schoch
    W Kern
    S Schnittger
    W Hiddemann
    T Haferlach
    Leukemia, 2004, 18 : 120 - 125
  • [39] PPM1D Mutations Are Rare in De Novo and Therapy-Related Acute Myeloid Leukemia
    Kartal-Kaess, Mutlu
    Bochtler, Tilmann
    Kraft, Bianca
    Kirsch, Michael
    Maier, Bettina
    Stoelzel, Friedrich
    Mohr, Brigitte
    Kramer, Michael
    Rollig, Christoph
    Thiede, Christian
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Mueller-Tidow, Carsten
    Kraemer, Alwin
    BLOOD, 2018, 132
  • [40] A Comparison of Therapy-Related and De Novo Chronic Myelomonocytic Leukemia
    Ordobazari, A.
    Olteanu, H.
    Kroft, S. H.
    Harrington, A. M.
    MODERN PATHOLOGY, 2014, 27 : 369A - 369A
12345